Skip to content

to study the Efficacy of pain relief from erector spinae plane block for patients undergoing abdominal surgery

A study of assess the efficacy of ultrasound guided bilateral erector spinae block(ESPB) for abdominal surgery under general / spinal anaesthesia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043314
Enrollment
70
Registered
2022-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K353- Acute appendicitis with localizedperitonitis Health Condition 2: K810- Acute cholecystitis Health Condition 3: K400- Bilateral inguinal hernia, with obstruction, without gangrene Health Condition 4: N72- Inflammatory disease of cervix uteri

Interventions

Intervention1: erector spinae plan block with general anaesthesia / spinal anaesthesia: Erector spinae plane Block using ROPIVACAINE 0.25% 15 ml + 15 ml bilaterally with dexmedetomidine 1mcg /kg at t

Sponsors

JLN MEDICAL COLLEGE AJMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group between 18 and 60 years, Body weight 30 to 80kg , Patients belonging to ASA (American Society of Anaesthesiologists) class 1 and 2 Patients undergoing abdominal surgery of duration 1 to 2 hours in theatre with haemoglobin atleast 9 gm/dl, Patient free from any associated acute or chronic systemic illness

Exclusion criteria

Exclusion criteria: Patients not willing to participate in the study Uncooperative patients Patient with chronic pain or on long-term analgesics Any known hypersensitivity or contraindication to bupivacaine Local pathology at the site of injection or disability limiting the performance of block,(deformity of spine) Patients receiving beta blockers or cardiac drugs. History of convulsion, allergy to the drug used, bleeding disorder, severe neurological deficit, thyroid disorder Patient with history of respiratory, cardiac, hepatic or renal disease (necessitating classification in ASA Class III or above) Patients having a history of significant neurological, psychiatric, or neuromuscular disorders Pregnant, lactating mothers

Design outcomes

Primary

MeasureTime frame
Comparison of Number and frequency of postoperative analgesia required in both the groups for First 36 hours Postoperatively To assess the effective analgesia by visual analog scale (VAS) scoreTimepoint: Around 1 year

Secondary

MeasureTime frame
to assess hemodynamic changes to assess and compare the adverse effect to assess sensory and motor block if any in espbTimepoint: around 1 year

Countries

India

Contacts

Public ContactDr Kavita Jain

JLN medical college, Ajmer

drkavitajain15@gmail.com9414006151

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026